Hot Products

Mollugin
Catalog No: CFN98930

Mollugin is a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway. Mollugin may be a novel therapeutic candidate for bone loss-associated disorders including osteoporosis, rheumatoid arthritis, and periodontitis. Mollugin has anticancer efficacy, can modulate the HER2, HO-1, Nrf2 , and NF- κB pathways.

Momordicine I
Catalog No: CFN92076

Momordicine I has anti-diabetic and antifeedant activities.

Momordicine II
Catalog No: CFN95167

Momordicine II may have antidiabetic activity, it significantly stimulated insulin secretion. It also can deter oviposition by L. trifolii significantly.

Momordicine V
Catalog No: CFN95164

Momordicine V can deter significantly the oviposition by L. trifolii on host plant leaves treated at 26.16 microg/cm2 leaf surface.

Momordicoside A
Catalog No: CFN93279

Momordicoside A has the inhibition effect on PIP1B.

Momordicoside F1
Catalog No: CFN92306

Momordicoside F1 may have antiproliferative activities against MCF-7, WiDr, HEp-2, and Doay human tumor cell lines.

Momordicoside G
Catalog No: CFN97295

Momordicosides K and L, the main bitter taste triterpene glycosides in Bitter melon; and bitter melon has been reported to have hypoglycemic, anti atherogenic and anti HIV activities.

Momordicoside I aglycone
Catalog No: CFN97300

Reference standards.

Momordicoside K
Catalog No: CFN92305

Momordicoside K has antidiabetic activity.

Momordicoside L
Catalog No: CFN92307

Momordicoside L has hypoglycaemic / antihyperglycaemic activities.